Related references
Note: Only part of the references are listed.Farnesoid X receptor agonists in biliary tract disease
Stefano Fiorucci et al.
CURRENT OPINION IN GASTROENTEROLOGY (2009)
Kupffer Cells Mediate Leptin-Induced Liver Fibrosis
Jianhua Wang et al.
GASTROENTEROLOGY (2009)
Non-alcoholic steatohepatitis and animal models: Understanding the human disease
Marta Varela-Rey et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Bile acids: regulation of synthesis
John Y. L. Chiang
JOURNAL OF LIPID RESEARCH (2009)
Farnesoid X receptor induces GLUT4 expression through FXR response element in the GLUT4 promoter
Hong Shen et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2008)
Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress
Nobuo Cho et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2008)
The farnesoid X receptor (FXR) as a new target in non-alcoholic steatohepatitis
B. Cariou
DIABETES & METABOLISM (2008)
Metformin therapy and clinical uses
John H. B. Scarpello et al.
DIABETES & VASCULAR DISEASE RESEARCH (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
Animal models of NASH: Getting both pathology and metabolic context right
Claire Z. Larter et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
Nonalcoholic fatty liver disease: Pathogenesis and potential for nuclear receptors as therapeutic targets
Jacob George et al.
MOLECULAR PHARMACEUTICS (2008)
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes
Adilson Guilherme et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Effects of rosiglitazone on the liver histology and mitochondrial function in ob/ob mice
Inmaculada Garcia-Ruiz et al.
HEPATOLOGY (2007)
Targeting farnesoid X receptor for liver and metabolic disorders
Stefano Fiorucci et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Review:: Peroxisome proliferator-activated receptor γ and adipose tissue -: Understanding obesity-related changes in regulation of lipid and glucose metabolism
Arya M. Sharma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Mechanisms linking obesity to insulin resistance and type 2 diabetes
Steven E. Kahn et al.
NATURE (2006)
The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo
Giovanni Rizzo et al.
MOLECULAR PHARMACOLOGY (2006)
Treatment of non-alcoholic fatty liver disease
LA Adams et al.
POSTGRADUATE MEDICAL JOURNAL (2006)
The farnesoid X receptor modulates adiposity and peripheral insulin sensitivity in mice
B Cariou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Farnesoid X receptor is essential for normal glucose homeostasis
K Ma et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Development of insulin resistance and hyperphagia in Zucker fatty rats
HA Durham et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2006)
Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice
YQ Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The farnesoid X receptor modulates hepatic carbohydrate metabolism during the fasting-refeeding transition
D Duran-Sandoval et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of disease: Retinoid X receptor heterodimers in the metabolic syndrome
AI Shulman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Protective effects of 6-ethyl chenodeoxycholic acid, a farnesoid X receptor ligand, in estrogen-induced cholestasis
S Fiorucci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Regulation of pyruvate dehydrogenase kinase expression by the farnesoid X receptor
RS Savkur et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Peroxisome proliferator-activated receptor-γ coactivator 1α (PGC-1α) regulates triglyceride metabolism by activation of the nuclear receptor FXR
YQ Zhang et al.
GENES & DEVELOPMENT (2004)
Prevention of cholesterol gallstone disease by FXR agonists in a mouse model
A Moschetta et al.
NATURE MEDICINE (2004)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c
M Watanabe et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle
CL Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cellular mechanisms of insulin resistance
GI Shulman
JOURNAL OF CLINICAL INVESTIGATION (2000)
Share Paper
